AquaBounty Technologies, Inc. (AQB) Stock

AquaBounty Technologies, Inc. is a pioneering biotechnology firm dedicated to advancing productivity within the commercial aquaculture sector across the United States and Canada. The company specializes in genetic, genomic, and research activities focused on optimizing fish health and nutrition. Central to its innovation is the development of AquAdvantage Salmon, a bioengineered Atlantic salmon designed specifically for human consumption. In addition to its flagship product, AquaBounty Technologies also markets conventional Atlantic salmon, salmon eggs, fry, and related byproducts to meet diverse market demands.

Founded in 1991 and headquartered in Maynard, Massachusetts, AquaBounty Technologies initially operated under the name Aqua Bounty Farms, Inc. before rebranding in June 2004. The company's strategic focus on biotechnology underscores its commitment to sustainability and food security, leveraging scientific advancements to enhance aquaculture practices. Through rigorous research and development initiatives, AquaBounty Technologies aims to address global challenges in seafood production while promoting environmentally responsible farming solutions.

With a mission to revolutionize aquaculture through innovative biotechnological solutions, AquaBounty Technologies continues to lead the industry in bioengineered fish technologies. By integrating cutting-edge genetic research with sustainable farming practices, the company aims to bolster food production capabilities and meet the growing demand for safe, nutritious seafood worldwide.